PDL BioPharma Q3 EPS $0.04 Misses $0.06 Estimate, Sales $4.12M Miss $5.50M Estimate
PDL BioPharma Q3 EPS $0.04 Misses $0.06 Estimate, Sales $4.12M Miss $5.50M Estimate
PDL BioPharma第三季度每股收益0.04美元未达到0.06美元预期，销售额412万美元未达到550万美元预期
PDL BioPharma (NASDAQ:PDLI) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.06 by 33.33 percent. This is a 55.56 percent decrease over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $4.12 million which missed the analyst consensus estimate of $5.50 million by 25.18 percent. This is a 90.68 percent decrease over sales of $44.16 million the same period last year.
PDL BioPharma(纳斯达克：PDLI)公布季度每股收益为0.04美元，低于分析师普遍预期的0.06美元，降幅为33.33%。这比去年同期每股0.09美元的收益下降了55.56%。该公司公布季度销售额为412万美元，低于分析师普遍预期的550万美元，降幅为25.18%。这比去年同期4416万美元的销售额下降了90.68%。